Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ºÎºÐ°£Áú ȯÀÚ¿¡¼­ Vigabatrin »ç¿ëÈÄ ¹ß»ýÇÑ Multifocal Action Myoclonus Vigabatrin-Induced Multifocal Action Myoclonus in a Patient with Partial Epilepsy

´ëÇÑ°£ÁúÇÐȸÁö 1999³â 3±Ç 2È£ p.206 ~ 208
ÀÌ»ó¾Ï, Á¤Á¾ÇÊ, °­Áß±¸,
¼Ò¼Ó »ó¼¼Á¤º¸
ÀÌ»ó¾Ï ( Lee Sang-Ahm ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ïÁß¾Óº´¿ø ½Å°æ°úÇб³½Ç

Á¤Á¾ÇÊ ( Jeong Jong-Pil ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ïÁß¾Óº´¿ø ½Å°æ°úÇб³½Ç
°­Áß±¸ ( Kang Joong-Koo ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ïÁß¾Óº´¿ø ½Å°æ°úÇб³½Ç

Abstract


Vigabatrin-induced myoclonus is rarely described in adult with partial epilepsy, We report vigavatrin-induced mulrifocal action myoclonus in a 34 year-old female with symptomatic partial epilepsy. Hwe seizures were resistant to catbamazepine. Vigabatrin was started as add-on therapy and multifocal action myoclonus was developed one month later. Myoclonus disappeared after withdrawal of vigabatrin and reappeared with re-use of it. Based on clinical features of myoclonus, her myoclonus may be non-epileptic in nature.

Å°¿öµå

±Ù°£´ë;ºÎºÐ°£Áú
Vigabatrin

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KoreaMed
KAMS